Syndax Pharmaceuticals(DE:1T3)
€7.86-0.48 (-5.78%)
DE:1T3
Syndax Pharmaceuticals ownership
€7.86
At close:-0.48 (-5.78%)
Syndax Pharmaceuticals (1T3) Ownership - Who Owns Syndax Pharmaceuticals?
4 Followers
Syndax Pharmaceuticals (1T3) Ownership Overview
- 1.59% Insiders
- 17.30% Mutual Funds
- 55.60% Other Institutional Investors
- 14.44% ETFs
- 11.08% Public Companies and Individual Investors
The ownership structure of Syndax Pharmaceuticals (DE:1T3) stock is a mix of institutional, retail, and individual investors. Approximately 87.34% of the company’s stock is owned by Institutional Investors, 1.59% is owned by Insiders, and 11.08% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Syndax Pharmaceuticals (DE:1T3) stock is a mix of institutional, retail, and individual investors. Approximately 87.34% of the company’s stock is owned by Institutional Investors, 1.59% is owned by Insiders, and 11.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 01, 2026 | Keith Goldan | $22,351 | |
| Jun 01, 2026 | Michael Metzger | $130,025 | |
| Feb 09, 2026 | Keith Goldan | $71,678 | |
| Feb 09, 2026 | Michael Metzger | $360,682 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | €26,276,534 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 9,268,460 | Institution | 10.30% | 79,838,514 |
| Ishares | 4,413,030 | Institution | 4.90% | 38,013,840 |
| Vanguard | 4,118,359 | Institution | 4.57% | 35,475,544 |
| Vanguard Index Funds | 3,837,471 | Institution | 4.26% | 33,055,975 |
| James E. Flynn | 3,779,900 | Institution | 4.20% | 32,560,059 |
| Spdr | 2,940,682 | Institution | 3.27% | 25,331,035 |
| Franklin Strategic Series | 1,510,840 | Institution | 1.68% | 13,014,376 |
| Fidelity Salem Street Trust | 1,334,283 | Institution | 1.48% | 11,493,514 |
| Michael Rockefeller | 1,330,805 | Institution | 1.48% | 11,463,554 |
| Dennis J Purcell | 1,316,806 | Institution | 1.46% | 11,342,967 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,837,471 | Institution | 4.26% | 33,055,975 |
| Franklin Strategic Series | 1,510,840 | Institution | 1.68% | 13,014,376 |
| Fidelity Salem Street Trust | 1,334,283 | Institution | 1.48% | 11,493,514 |
| Manager Directed Portfolios | 1,211,108 | Institution | 1.35% | 10,432,484 |
| Tiaa-cref Funds | 1,030,397 | Institution | 1.14% | 8,875,840 |
| Fidelity Concord Street Trust | 860,637 | Institution | 0.96% | 7,413,527 |
| Vanguard Scottsdale Funds | 614,737 | Institution | 0.68% | 5,295,345 |
| Delaware Group Equity Funds Iv | 540,000 | Institution | 0.60% | 4,651,560 |
| Blackrock Funds | 500,114 | Institution | 0.56% | 4,307,982 |
| Loomis Sayles Funds Ii | 499,843 | Institution | 0.56% | 4,305,648 |
FAQ
Who Owns Syndax Pharmaceuticals (DE:1T3)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 87.34% of the company's stock is held by institutional investors, 1.59% is held by insiders, and 11.08% is held by public companies and individual investors.
What percentage of Syndax Pharmaceuticals (DE:1T3) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 87.34% of Syndax Pharmaceuticals (DE:1T3) stock is held by institutional investors: 17.30% by mutual funds, 14.44% by ETFs and 55.60% by other institutional investors.
What percentage of Syndax Pharmaceuticals (DE:1T3) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 11.08% of Syndax Pharmaceuticals (DE:1T3) stock is held by public companies and individual investors.
Who owns the most shares of Syndax Pharmaceuticals (DE:1T3)?
BlackRock, Inc. owns the most shares of Syndax Pharmaceuticals (DE:1T3).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

